Olink® Target 96 Immuno-Oncology Panels
Thoroughly validated, high-performance protein biomarker panels available for immuno-oncology studies.
Receive your quote directly from the manufacturer.
Super
Immuno-Oncology
Excellent product, very user friendly software to analyze the data.
Review Date: 16 Jan 2024 | Olink Proteomics
Olink® Target 96 panels specialize in key disease areas and important biological processes, and accelerate targeted protein biomarker research through high-multiplex immunoassays, providing uncompromised data quality and performance.
Key features & benefits
- Allows for simultaneous analysis of 92 protein biomarkers
- Uses only 1 µL of biological sample
- Exceptional data quality through relative (NPX) quantification
- qPCR readout with unparalleled sensitivity, specificity, and precision
- All assays are subject to Olink’s strict technical validation and quality control procedures
Olink Target 96 Immuno-Oncology panels offer a broad selection of proteins associated with biological functions linked to immune response and immuno-oncology diseases. Categorization of the proteins included in the panel was carried out via referral to widely used public-access bioinformatic databases, including Uniprot, Human Protein Atlas, Gene Ontology (GO) and DisGeNET.
